Hanson McClain Advisors »

Day One Biopharmaceuticals I shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $889 126 7.06
2025-06-30 $845 130 6.50
2025-03-31 $181 23 7.91
2024-12-31 $75 6 12.50
2024-09-30 $84 6 14.00

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Day One Biopharmaceuticals I

FMR
BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
Deerfield Management Company
Franklin Resources
Rubric Capital Management
State Street Corporation
Vestal Point Capital
Pictet Asset Management Holding SA
Alyeska Investment Group
Braidwell
Geode Capital Management
AIGH Capital Management
MAK Capital One

View all funds holding Day One Biopharmaceuticals I